INMED PHARMACEUTICALS INC. Borrowings under Guaranteed Investment Agreements
INMED PHARMACEUTICALS INC. (INM) had Borrowings under Guaranteed Investment Agreements of $39.67 thousand as of 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Balance Sheet › Liabilities
us-gaap:BorrowingsUnderGuaranteedInvestmentAgreements · last filed 2026-09-09
- 2026-06-30: Borrowings under Guaranteed Investment Agreements $39.67K.
- 2026-03-31: Borrowings under Guaranteed Investment Agreements $41.63K.
- 2025-12-31: Borrowings under Guaranteed Investment Agreements $43.38K.
- 2025-09-30: Borrowings under Guaranteed Investment Agreements $42.86K.
| Period end | Borrowings under Guaranteed Investment Agreements |
|---|---|
| 2026-06-30 | $39.67K S-4/A · filed 2026-09-09 |
| 2026-03-31 | $41.63K S-4 · filed 2026-07-02 |
| 2025-12-31 | $43.38K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $42.86K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $43.38K S-4/A · filed 2026-09-09 |
| 2025-03-31 | $40.85K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $40.79K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $43.20K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $43.06K S-4 · filed 2026-07-02 |
| 2023-12-31 | $44.46K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $42.94K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $44.42K 10-K · filed 2024-09-30 |
| 2022-06-30 | $44.68K 10-K · filed 2023-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |